Also trades as: 0JW9.L (LSE) · $vol 0M
LITS NASDAQ
Lite Strategy, Inc.
1W: -12.8%
1M: -8.4%
3M: -0.9%
YTD: -29.2%
$1.11
+0.02 (+1.83%)
Weekly Expected Move ±7.5%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$37.1M
52W Range0.95-9
Volume222,239
Avg Volume292,565
Beta0.08
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJustin J. File
Employees4
SectorFinancial Services
IndustryAsset Management - Cryptocurrency
IPO Date2003-12-18
Websitelitestrategy.com
9920 Pacific Heights Blvd.
San Diego, CA 92121
US
San Diego, CA 92121
US
858 369 7100
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| File Justin J. | A-Award | 455,000 | $2.02 | 2026-02-12 |
| Flynn James P | P-Purchase | 70,000 | $1.40 | 2025-12-19 |
| Schornstein Alexande | S-Sale | 690,611 | $1.37 | 2025-12-18 |
| Flynn James P | P-Purchase | 12,100 | $1.88 | 2025-11-19 |
| File Justin J. | A-Award | 180,000 | $2.02 | 2025-11-14 |